Optilamid (Brinzolamide)

Brinzolamide, the active ingredient in Optilamid, is a carbonic anhydrase inhibitor presented as a 10 mg/mL ophthalmic solution for topical eye use. It lowers intra‑ocular pressure in patients with ocular hypertension and open‑angle glaucoma. GNH USA supplies Optilamid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Optilamid is a carbonic anhydrase inhibitor used in the management of ocular conditions that affect intra‑ocular pressure. - Open‑angle glaucoma: Reduces the risk of visual field loss by decreasing the production of aqueous humour. - Ocular hypertension: Low the eye pressure to prevent progression to the development  of the the    t   g  \,  ", -  ",